Regulation of NF-κB signaling by the A20 deubiquitinase

Noula Shembade, Edward W. Harhaj

Research output: Contribution to journalArticle

95 Citations (Scopus)

Abstract

The NF-κB transcription factor is a central mediator of inflammatory and innate immune signaling pathways. Activation of NF-κB is achieved by K63-linked polyubiquitination of key signaling molecules which recruit kinase complexes that in turn activate the Iδ °B kinase (IKK). Ubiquitination is a highly dynamic process and is balanced by deubiquitinases that cleave polyubiquitin chains and terminate downstream signaling events. The A20 deubiquitinase is a critical negative regulator of NF-κB and inflammation, since A20-deficient mice develop uncontrolled and spontaneous multi-organ inflammation. Furthermore, specific polymorphisms in the A20 genomic locus predispose humans to autoimmune disease. Recent studies also indicate that A20 is an important tumor suppressor that is inactivated in B-cell lymphomas. Therefore, targeting A20 may form the basis of novel therapies for autoimmune disease and lymphomas.

Original languageEnglish
Pages (from-to)123-130
Number of pages8
JournalCellular and Molecular Immunology
Volume9
Issue number2
DOIs
StatePublished - Mar 1 2012

Fingerprint

Autoimmune Diseases
Phosphotransferases
Polyubiquitin
Inflammation
Ubiquitination
B-Cell Lymphoma
Lymphoma
Transcription Factors
Neoplasms
Deubiquitinating Enzymes
Therapeutics
3'-(1-butylphosphoryl)adenosine

Keywords

  • A20
  • inflammation
  • NF-κB
  • ubiquitin

ASJC Scopus subject areas

  • Immunology and Allergy
  • Infectious Diseases
  • Immunology

Cite this

Regulation of NF-κB signaling by the A20 deubiquitinase. / Shembade, Noula; Harhaj, Edward W.

In: Cellular and Molecular Immunology, Vol. 9, No. 2, 01.03.2012, p. 123-130.

Research output: Contribution to journalArticle

@article{9695e4bb5fa94b399aecc45ce6f05f5e,
title = "Regulation of NF-κB signaling by the A20 deubiquitinase",
abstract = "The NF-κB transcription factor is a central mediator of inflammatory and innate immune signaling pathways. Activation of NF-κB is achieved by K63-linked polyubiquitination of key signaling molecules which recruit kinase complexes that in turn activate the Iδ °B kinase (IKK). Ubiquitination is a highly dynamic process and is balanced by deubiquitinases that cleave polyubiquitin chains and terminate downstream signaling events. The A20 deubiquitinase is a critical negative regulator of NF-κB and inflammation, since A20-deficient mice develop uncontrolled and spontaneous multi-organ inflammation. Furthermore, specific polymorphisms in the A20 genomic locus predispose humans to autoimmune disease. Recent studies also indicate that A20 is an important tumor suppressor that is inactivated in B-cell lymphomas. Therefore, targeting A20 may form the basis of novel therapies for autoimmune disease and lymphomas.",
keywords = "A20, inflammation, NF-κB, ubiquitin",
author = "Noula Shembade and Harhaj, {Edward W.}",
year = "2012",
month = "3",
day = "1",
doi = "10.1038/cmi.2011.59",
language = "English",
volume = "9",
pages = "123--130",
journal = "Cellular and Molecular Immunology",
issn = "1672-7681",
publisher = "Nature Publishing Group",
number = "2",

}

TY - JOUR

T1 - Regulation of NF-κB signaling by the A20 deubiquitinase

AU - Shembade, Noula

AU - Harhaj, Edward W.

PY - 2012/3/1

Y1 - 2012/3/1

N2 - The NF-κB transcription factor is a central mediator of inflammatory and innate immune signaling pathways. Activation of NF-κB is achieved by K63-linked polyubiquitination of key signaling molecules which recruit kinase complexes that in turn activate the Iδ °B kinase (IKK). Ubiquitination is a highly dynamic process and is balanced by deubiquitinases that cleave polyubiquitin chains and terminate downstream signaling events. The A20 deubiquitinase is a critical negative regulator of NF-κB and inflammation, since A20-deficient mice develop uncontrolled and spontaneous multi-organ inflammation. Furthermore, specific polymorphisms in the A20 genomic locus predispose humans to autoimmune disease. Recent studies also indicate that A20 is an important tumor suppressor that is inactivated in B-cell lymphomas. Therefore, targeting A20 may form the basis of novel therapies for autoimmune disease and lymphomas.

AB - The NF-κB transcription factor is a central mediator of inflammatory and innate immune signaling pathways. Activation of NF-κB is achieved by K63-linked polyubiquitination of key signaling molecules which recruit kinase complexes that in turn activate the Iδ °B kinase (IKK). Ubiquitination is a highly dynamic process and is balanced by deubiquitinases that cleave polyubiquitin chains and terminate downstream signaling events. The A20 deubiquitinase is a critical negative regulator of NF-κB and inflammation, since A20-deficient mice develop uncontrolled and spontaneous multi-organ inflammation. Furthermore, specific polymorphisms in the A20 genomic locus predispose humans to autoimmune disease. Recent studies also indicate that A20 is an important tumor suppressor that is inactivated in B-cell lymphomas. Therefore, targeting A20 may form the basis of novel therapies for autoimmune disease and lymphomas.

KW - A20

KW - inflammation

KW - NF-κB

KW - ubiquitin

UR - http://www.scopus.com/inward/record.url?scp=84858120447&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84858120447&partnerID=8YFLogxK

U2 - 10.1038/cmi.2011.59

DO - 10.1038/cmi.2011.59

M3 - Article

C2 - 22343828

AN - SCOPUS:84858120447

VL - 9

SP - 123

EP - 130

JO - Cellular and Molecular Immunology

JF - Cellular and Molecular Immunology

SN - 1672-7681

IS - 2

ER -